|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 4643 | Drugs / Medical | 02/06/2006
A major independent study indicates Bayer's antifibrinolytic agent Trasylol doubles the risk of kidney failure and causes other serious adverse events, including stroke and heart attack. Trasylol has been on the market for 13 years, and it reduces the loss of blood during surgery and is typically used during certain heart operations.
"The study raises serious questions about the continued use of Trasylol and suggests far less expensive alternatives are available that are equally effective and safe,"said the study's lead author, Dennis Mangano, also a member of the Ischemia Research and Education Foundation in California. Two generic drugs, aminocaproic acid and tranexamic acid were just as effective and safer, the research team concluded. Clinical Study In a recent study, data was collected from more than 4,300 patients undergoing revascularization surgery at more than 69 centers around the world between 1996 and 2000. The patients received either Trasylol, aminocaproic acid, tranexamic acid or no treatment. The Trasylol group had double the risk of renal failure requiring dialysis usually observed in patients undergoing complex coronary-artery surgery or primary surgery. The group also had a 48-percent increased risk of heart attack, a 109-percent increased risk of heart failure and a 181-percent increased risk of stroke or encephalopathy. The recent study comes as a blow to the German owned Bayer, which is pushing to have the drug used in all surgeries, not just in cases where there is a risk of excessive blood loss. If you or a family member suffered kidney failure, heart attack or stroke while on Trasylol, our attorneys may be able to assist you. Register your Bayer Healthcare ComplaintIf you or someone you know has been affected by this case, you may qualify for a money settlement as the result of your financial/economic or other damages that may be awarded either prior to a lawsuit or after the initiation of a lawsuit either currently in progress or filed just for you, possibly a class action lawsuit. Please simply register your complaint by clicking here for Bayer Healthcare, or click the red "submit" button on this page, and a lawyer will review your Bayer Healthcare complaint. By submitting your complaint, you are asking lawyers to contact you. You are under no obligation to accept their services and you are free to choose which lawyer you want to work with. Lawyers are usually paid out of the proceeds of the settlement or verdict rendered - the lawyers work on "contingency" by fronting the costs of your lawsuit based on their belief that they will recover a settlement for you. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest A nationwide class action has been filed against the manufacturer of weight-loss supplement CortiSlim, Window Rock Health Laboratories, Inc., on behalf of all purchasers of the supplement, who allege that the company has used false, deceptive, and misleading advertising to sell its products in violation of California consumer protection laws. The parties have reached a tentative $4.5 million settlement in several actions filed against PHP Healthcare Corporation and certain of its officers and directors by stockholders who purchased the company's common stock between July 27, 1995, and November 19, 1998. Persons eligible to participate in the settlement must file a proof of claim postmarked no later than May 13, 2004. Would you want to take drugs that someone else had sent back to the pharmacy? The class has been certified in a class action filed against IPC Pharmacy and five related companies on behalf of Hawaiians who allege that the company accepted pills returned by nursing homes and recycled them either by returning them to bulk container bottles or by relabeling them in violation of state consumer protection laws. In the wake of Merck’s worldwide recall of the pain medication Vioxx, a growing number and variety of legal actions have been filed against the embattled pharmaceutical giant. This latest is brought under the Federal Employee Retirement Income Security Act (ERISA). Participants in Merck’s employee stock purchase plans say the company’s attempts to cover up the health risks of Vioxx, followed by the eventual recall of the drug, decimated the value of their company stock purchases. The plaintiffs seek damages for the lost value of their stock. A class action lawsuit was filed in federal court in Baton Rouge that claims a New York medical supply company sold illegal tissue and bone to Baton Rouge hospital Our Lady of the Lake Regional Medical Center and other unnamed hospitals in Louisiana. Darrel Bourque says surgeons notified him in January that tissue transplanted in his neck during spinal surgery a year ago came from Biomedical Tissue Services.
The parties have reached a tentative $1.25 million settlement in a class action filed against MiniMed, Inc., and certain of its officers and directors by stockholders who held the company's common stock as of July 16, 2001. Persons eligible to participate in the settlement must submit a proof of claim form postmarked no later than September 13, 2004. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
